MedTech Acquisition (MTAC) Short Interest Ratio & Short Volume → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free MTAC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis MedTech Acquisition Short Interest DataCurrent Short Volume2,900 sharesPrevious Short Volume3,600 sharesChange Vs. Previous Month-19.44%Dollar Volume Sold Short$28,275.00Short Interest Ratio / Days to Cover0.3Last Record DateJuly 31, 2023Outstanding Shares7,390,000 sharesFloat Size1,140,000 sharesShort Percent of Float0.25%Today's Trading Volume183,276 sharesAverage Trading Volume9,656 sharesToday's Volume Vs. Average1,898% Short Selling MedTech Acquisition ? Sign up to receive the latest short interest report for MedTech Acquisition and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTAC Short Interest Over TimeMTAC Days to Cover Over TimeMTAC Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story MedTech Acquisition Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20232,900 shares $28,275.00 -19.4%0.3%0.3 $9.75 7/15/20233,600 shares $38,160.00 No Change0.3%0.9 $10.60 6/30/20233,600 shares $37,728.00 -43.8%0.2%1.4 $10.48 6/15/20236,400 shares $67,776.00 +137.0%0.3%2.4 $10.59 5/31/20232,700 shares $28,107.00 -10.0%0.1%1.7 $10.41 5/15/20233,000 shares $30,960.00 No Change0.2%6 $10.32 Get the Latest News and Ratings for MTAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter. 2/28/20232,700 shares $27,324.00 No Change0.0%0.5 $10.12 2/15/20232,700 shares $27,324.00 -42.6%0.0%0.3 $10.12 1/31/20234,700 shares $47,423.00 No Change0.0%0.2 $10.09 1/15/20234,700 shares $47,423.00 +30.6%0.0%0.1 $10.09 12/30/20223,600 shares $36,108.00 No Change0.0%0.1 $10.03 12/15/20223,600 shares $36,144.00 -29.4%0.0%0.1 $10.04 11/30/20225,100 shares $51,306.00 -3.8%0.0%0.1 $10.06 11/15/20225,300 shares $53,159.00 +1.9%0.0%0.1 $10.03 10/31/20225,200 shares $52,000.00 +18.2%0.0%0.2 $10.00 10/15/20224,400 shares $43,780.00 +4.8%0.0%0.1 $9.95 9/30/20224,200 shares $41,706.00 +16.7%0.0%0.1 $9.93 9/15/20223,600 shares $35,712.00 -14.3%0.0%0.1 $9.92 8/31/20224,200 shares $41,664.00 -80.0%0.0%0.1 $9.92 8/15/202221,000 shares $208,110.00 -28.6%0.1%0.2 $9.91 7/31/202229,400 shares $290,472.00 -21.4%0.1%0.3 $9.88 7/15/202237,400 shares $369,138.00 -11.0%0.2%0.4 $9.87 6/30/202242,000 shares $413,700.00 +324.2%0.2%0.7 $9.85 6/15/20229,900 shares $97,218.00 -23.3%0.0%0.1 $9.82 5/31/202212,900 shares $126,678.00 +3.2%0.1%0.1 $9.82 5/15/202212,500 shares $122,435.00 -10.1%0.1%0.1 $9.79 4/30/202213,900 shares $136,637.00 -38.2%N/A0.1 $9.83 4/15/202222,500 shares $221,175.00 -35.5%N/A0.1 $9.83 3/31/202234,900 shares $342,020.00 -82.0%N/A0.1 $9.80 3/15/2022193,500 shares $1.90 million -66.2%N/A0.8 $9.80 2/28/2022572,600 shares $5.70 million +6.7%N/A5.5 $9.96 2/15/2022536,900 shares $5.34 million -5.6%2.2%6.8 $9.95 1/31/2022568,500 shares $5.61 million +6.5%N/A10.8 $9.86 1/15/2022533,900 shares $5.28 million +24.1%N/A9.3 $9.89 12/31/2021430,200 shares $4.25 million -0.4%N/A6.6 $9.88 12/15/2021431,900 shares $4.28 million -2.6%N/A5.8 $9.92 11/30/2021443,400 shares $4.42 million -6.5%N/A6.6 $9.97 11/15/2021474,200 shares $4.72 million -45.2%N/A6 $9.96 10/29/2021864,600 shares $8.60 million +0.1%N/A6 $9.95 10/15/2021863,700 shares $8.55 million -1.5%N/A6.5 $9.90Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story MTAC Short Interest - Frequently Asked Questions What is MedTech Acquisition's current short interest? Short interest is the volume of MedTech Acquisition shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 2,900 shares of MTAC short. 0.25% of MedTech Acquisition's shares are currently sold short. Learn More on MedTech Acquisition's current short interest. What is a good short interest percentage for MedTech Acquisition? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of MedTech Acquisition's floating shares are currently sold short. Is MedTech Acquisition's short interest increasing or decreasing? MedTech Acquisition saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 2,900 shares, a decline of 19.4% from the previous total of 3,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MedTech Acquisition's float size? MedTech Acquisition currently has issued a total of 7,390,000 shares. Some of MedTech Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MedTech Acquisition currently has a public float of 1,140,000 shares. How does MedTech Acquisition's short interest compare to its competitors? 0.25% of MedTech Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MedTech Acquisition: Personalis, Inc. (2.64%), Biodesix, Inc. (1.12%), Exagen Inc. (0.26%), DermTech, Inc. (10.31%), Sera Prognostics, Inc. (1.15%), 111, Inc. (0.04%), AlloVir, Inc. (5.48%), Monogram Orthopaedics, Inc. (0.18%), Forian Inc. (1.14%), BrainsWay Ltd. (0.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short MedTech Acquisition stock? Short selling MTAC is an investing strategy that aims to generate trading profit from MedTech Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MedTech Acquisition? A short squeeze for MedTech Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MTAC, which in turn drives the price of the stock up even further. How often is MedTech Acquisition's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTAC, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Personalis Short Interest Data Biodesix Short Interest Data Exagen Short Interest Data DermTech Short Interest Data Sera Prognostics Short Interest Data 111 Short Interest Data AlloVir Short Interest Data Monogram Orthopaedics Short Interest Data Forian Short Interest Data BrainsWay Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTAC) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research